Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
CNS drugs - 28(2014), 5 vom: Mai, Seite 389-399 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bigal, Marcelo E. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Chronic Migraine |
| RVK: |
|---|
| doi: |
10.1007/s40263-014-0156-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2037657005 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2037657005 | ||
| 003 | DE-627 | ||
| 005 | 20230507220437.0 | ||
| 007 | tu | ||
| 008 | 200819s2014 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40263-014-0156-4 |2 doi | |
| 035 | |a (DE-627)OLC2037657005 | ||
| 035 | |a (DE-He213)s40263-014-0156-4-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q AVZ |
| 084 | |a PHARM |2 fid | ||
| 084 | |a XA 37190 |q AVZ |2 rvk | ||
| 084 | |a 44.40 |2 bkl | ||
| 084 | |a 44.91 |2 bkl | ||
| 084 | |a 44.38 |2 bkl | ||
| 100 | 1 | |a Bigal, Marcelo E. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a Migraine |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Sumatriptan |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Chronic Migraine |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Trigeminal Ganglion |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Zolmitriptan |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Walter, Sarah |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t CNS drugs |d [Heidelberg] : Springer, 1994 |g 28(2014), 5 vom: Mai, Seite 389-399 |w (DE-627)182392813 |w (DE-600)1203800-3 |w (DE-576)043086012 |x 1172-7047 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2014 |g number:5 |g month:05 |g pages:389-399 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s40263-014-0156-4 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-PSY | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4012 | ||
| 936 | r | v | |a XA 37190 |
| 936 | b | k | |a 44.40 |q AVZ |
| 936 | b | k | |a 44.91 |q AVZ |
| 936 | b | k | |a 44.38 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 28 |j 2014 |e 5 |c 05 |h 389-399 | ||